Still, a decrease in growth is still growth, right?
Premature infants receiving steroid therapy have a decrease in growth velocity (Stark et al, 2001), continued growth delay and neuromotor dysfunction in toddlerhood (Yeh et al, 1998) and delayed motor milestones.
However, a decrease in growth or fermentation rate (Björkqvist et al., 1997; Nissen et al., 2000b; Hubmann et al., 2011) or decreased stress tolerance (Pagliardini et al., 2013) often hampers industrial applicability of the resulting strains.
Additionally, a decrease in nerve growth factor (NGF) in STZ-treated rats was prevented by taurine supplementation (Obrosova et al. 2001a).
Second, as large females usually produce larger offspring of higher viability (Trippel 1995; Walsh et al. 2006), a decrease in growth could impair the recruitment and consequently the long-term yield of the population.
Grigatti et al. (2007) and Prez-Murcia et al. (2006) also reported a decrease in phosphorus of growth media containing green waste compost and sewage sludge.
Likewise, APPL1 knockdown in zebrafish led to a decrease in growth factor-induced Akt signaling with no impact on MAPK (Schenck et al., 2008).
Nesprin-1 knockout in mice results in a decrease in survival rates, growth, and exercise capacity and increased variability in body weight (Zhang et al. 2010).
